The study provides strong clinical evidence that could drive adoption of SilverCloud by health plans and employers. While near-term revenue impact is modest, this validates the product differentiation. Monitor for partnership announcements and potential acceleration in contract wins.
Price Chart
Executive Summary
Amwell announced results from a large NIH-funded randomized trial published in Nature Human Behaviour, showing SilverCloud digital behavioral health reduced mental disorder prevalence by 3.8% at two years with 74.4% participation compared to 30.2% for traditional care. This strong clinical validation strengthens Amwell's positioning in the digital mental health market.
Key Facts
- Study published in Nature Human Behaviour, one of the largest independent trials of its kind, involving 6,205 students across 26 U.S. colleges.
- Students offered SilverCloud had 74.4% participation vs. 30.2% for traditional behavioral health solutions.
- 3.8% lower prevalence of any mental disorder at two years for those receiving digital behavioral healthcare compared to screening and referral.
- Potential up to $1.18 million in avoided mental health-related costs within the study sample.
- Positive impact consistent across minoritized students and those experiencing financial stress.
Financial Impact
The study suggests up to $1.18M in avoided mental health costs within the sample, but the overall revenue impact for Amwell is indirect and depends on commercialization.
Risk Factors
- Competitive digital mental health market with many alternatives (e.g., Teladoc, Headspace).
- Slow adoption cycles in healthcare and uncertainty in reimbursement.
- Study was funded by NIH and independent; commercial replication may vary.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3296495 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 3, 2026 4w ago | Insider Cluster | $13.25 $12.39 | ▼ −6.49% | ▼ −5.30% | $12.82 (−3.25%) |
Aug 4, 2026 8w ago | 8-K | $13.02 $12.83 | ▼ −1.46% | ▼ −0.86% | $12.82 (−1.54%) |
Jul 1, 2026 13w ago | 144 | $9.25 $10.84 | ▲ +17.19% | ▲ +17.60% | $12.82 (+38.59%) |
Jul 1, 2026 13w ago | Insider Cluster | $9.37 $10.77 | ▲ +14.94% | ▲ +17.13% | $12.82 (+36.82%) |
Jun 9, 2026 16w ago | DEFA14A | $8.50 $8.99 | ▲ +5.76% | ▲ +4.32% | $12.82 (+50.82%) |
Jun 3, 2026 17w ago | Insider Cluster | $8.65 $9.25 | ▲ +6.92% | ▲ +8.55% | $12.82 (+48.19%) |
Jun 1, 2026 17w ago | 144 | $8.35 $9.37 | ▲ +12.20% | ▲ +14.02% | $12.82 (+53.51%) |
May 18, 2026 19w ago | Press Release | $7.60 $8.69 | ▲ +14.33% | ▲ +12.14% | $12.82 (+68.66%) |
May 12, 2026 20w ago | 8-K | $7.69 $8.42 | ▲ +9.48% | ▲ +11.21% | $12.82 (+66.69%) |
May 5, 2026 21w ago | 8-K | $6.99 $8.46 | ▲ +21.01% | ▲ +18.23% | $12.82 (+83.38%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access